国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
残疾儿童药物临床试验伦理审查相关问题探讨
Discussion on Issues Related to Ethical Review of Clinical Trials of Drugs for Children with Disabilities
  
DOI:
中文关键词:  残疾儿童  药物临床试验  伦理审查  知情同意
英文关键词:Children with disabilities  Drug clinical trial  Ethical review  Informed consent
基金项目:“重大新药创制”科技重大专项(编号:2017ZX09304022)
作者单位
杜艾桦 华中科技大学同济医学院附属同济医院科研处 武汉 430030 
摘要点击次数: 1181
全文下载次数: 468
中文摘要:
      摘 要伦理委员会在药物临床试验受试者权益保护中扮演的角色至关重要。儿童药物临床试验是当前药物临床研究的热点和难点,其中残疾儿童作为受试者的临床试验更是存在较大的特殊性,其伦理审查也面临一定的挑战和个性化问题。我国对于残疾儿童药物临床试验的伦理审查相关的指导原则和法制存在较大盲区,因此亟需借鉴国际上针对该领域研究的相关成果进一步完善我国药物临床试验的伦理审查体系。本文从国际上残疾儿童临床试验伦理研究概况、残疾儿童生物伦理学研究关注要点等方面综述了残疾儿童药物临床中特殊的伦理问题。同时本文还引用两个国外临床试验案例来进一步阐明涉及残疾儿童的药物研究的伦理审查过程中需要思考和关注的问题,以期为我国残疾儿童药物临床试验伦理审查的研究提供参考和借鉴。
英文摘要:
      ABSTRACTEthics committee plays a crucial role in protecting the rights and interests of subjects in drug clinical trial. The clinical trial of children's drugs is the hot and also the difficult point in the current drug clinical trial, among which the clinical trial of children with disabilities as subjects is more special. And the ethical review of children with disabilities also faces some challenges and individualized problems. The related guiding principles and legal systems of the ethical review about children with disabilities in China are almost lacking. Therefore, it is urgent and necessary to learn from the relevant results of international studies in this field to further improve the Chinese ethical review system of drug clinical trials. From the aspects of general ethical study situation on clinical trial of children with disabilities and the focus point of the research on the bioethics of disabled children, this paper reviews the special ethical issues met in the clinical practice of children with disabilities. Meanwhile, this paper also cites two foreign clinical trial cases to further clarify the problems that need to be considered and paid attention to in the ethical review process of drug research when involving children with disabilities, so as to provide reference for the research on ethical review of drug clinical trials for children with disabilities in China.
查看全文  查看/发表评论  下载PDF阅读器
关闭